About Us

"From plant to patient, we truly care.™"

Australia — Importation and Supply

Our wholesale business is driven by a fully integrated supply chain management and distribution logistics. PharmaCann Global has direct access to and most-favoured partnerships with some of the world’s largest low-cost producers and cultivators in Canada, Europe, Latin America and the Caribbean. We deliver those substantial costs savings to patients, which provides the highest quality at affordable prices. We truly care.

Australia — Cultivation/Manufacturing

PharmaCann’s fully owned subsidiary, BioCann, has since applied for the federally-issued cultivation and manufacturing licences to expand our operations further. Our Team has developed proprietary formulations to ensure we are able to provide the highest quality medicines, at the best prices for patients. PharmaCann has commenced the supply of our low-cost medicines throughout Australia, with great success.


In New Zealand, PharmaCann Global is awaiting the issuance of federal import and sales licences for Scheduled Medicines. We have formed commercial agreements with a large team of pharmacists, agriculturalists, clinical researchers and wellness practitioners in New Zealand. These agreements allow our Company to commence supply to the domestic New Zealand market, and will ensure our Company is strategically positioned for the country’s referendum in 2020 to legalise the recreational cannabis industry.


In the United Kingdom, PharmaCann Global has partnered with a group of professional sports athletes to promote our recreational CBD sports supplement brand. These partnerships and commercial alignments will strengthen our presence in the UK and European Regions.

North America

In Canada, we have formed Commercial Agreements with medical, cosmetic, and business professionals to supply all forms of medical cannabis for human therapeutic purposes. PharmaCann Global is expanding our operations to Canada for a stronger global presence.

In United States we have formed an exclusive distribution agreement with the worlds leading medical vaporizer device, for the Australian and New Zealand geographical regions.